Skip to main content

GE HealthCare Technologies Inc. cash flow statement

  • GEHC · Nasdaq
  • Medical devices
  • Health Care Equipment
  • S&P 500
$83.02+1.44%Close 13 Nov 2026 · Market value $37.72B

In fiscal 2025 (the year to 31 Dec 2025), GE HealthCare Technologies Inc. generated $1.99B of operating cash flow and $1.50B of free cash flow, after $482.0M of capital expenditure.

From GE HealthCare Technologies Inc.'s annual and quarterly reports, each period checked against accounting identities; a figure that does not pass is left blank. Fiscal years follow the company's calendar, the latest ending 31 Dec 2025. TTM is the last four reported quarters added up.

Annual

GE HealthCare Technologies Inc. cash flow statement, annual
USDFY 2021FY 2022FY 2023FY 2024FY 2025TTM
Net income$2.25B$1.92B$1.57B$1.99B$2.08B$2.15B
Depreciation & amortization$625.0M$633.0M$610.0M$580.0M$578.0M$622.0M
Stock-based compensation$76.00M$67.00M$114.0M$125.0M$130.0M$152.0M
Operating cash flow$1.61B$2.11B$2.10B$1.95B$1.99B$2.42B
Operating cash flow margin9.1%11.5%10.7%9.9%9.6%11.2%
Capital expenditures$248.0M$310.0M$387.0M$401.0M$482.0M$526.0M
Acquisitions$1.48B$0.00$147.0M$313.0M$378.0M$2.40B
Free cash flow$1.36B$1.80B$1.71B$1.55B$1.50B$1.89B
Free cash flow margin7.7%9.8%8.8%7.9%7.3%8.7%
Free cash flow per share$2.99$3.97$3.74$3.38$3.29$4.15
Dividends paid$0.00$0.00$41.00M$55.00M$64.00M$64.00M
Gross share repurchases——$0.00$0.00$200.0M$300.0M
Stock issuance proceeds—$0.00$34.00M$33.00M$37.00M$24.00M
Net share repurchases—$0.00−$34.00M−$33.00M$163.0M$276.0M
Cash interest paid$21.00M$0.00$570.0M$550.0M$522.0M$559.0M
Free cash flow after SBC$1.28B$1.74B$1.60B$1.43B$1.38B$1.74B

Quarterly

GE HealthCare Technologies Inc. cash flow statement, quarterly
USDQ4 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Net income$403.0M$374.0M$428.0M$470.0M$721.0M$564.0M$486.0M$446.0M$589.0M$389.0M$561.0M$615.0M
Depreciation & amortization$144.0M$148.0M$149.0M$143.0M$140.0M$136.0M$148.0M$149.0M$146.0M$153.0M$160.0M$163.0M
Stock-based compensation$33.00M$34.00M$36.00M$22.00M$33.00M$22.00M$34.00M$38.00M$36.00M$35.00M$45.00M$36.00M
Operating cash flow$1.05B$419.0M−$119.0M$738.0M$913.0M$250.0M$94.00M$593.0M$1.05B$290.0M$168.0M$907.0M
Operating cash flow margin20.2%9.0%−2.5%15.2%17.2%5.2%1.9%11.5%18.4%5.7%3.2%16.5%
Capital expenditures$94.00M$145.0M$64.00M$90.00M$102.0M$152.0M$86.00M$110.0M$134.0M$178.0M$100.0M$114.0M
Acquisitions$0.00$0.00$259.0M$0.00$54.00M$269.0M$10.00M$0.00$99.00M$2.30B$4.00M$0.00
Free cash flow$956.0M$274.0M−$183.0M$648.0M$811.0M$98.00M$8.00M$483.0M$916.0M$112.0M$68.00M$793.0M
Free cash flow margin18.4%5.9%−3.8%13.3%15.2%2.1%0.2%9.4%16.1%2.2%1.3%14.4%
Free cash flow per share$2.09$0.60−$0.40$1.41$1.77$0.21$0.02$1.06$2.00$0.25$0.15$1.75
Dividends paid$13.00M$14.00M$14.00M$13.00M$14.00M$16.00M$16.00M$16.00M$16.00M$16.00M$16.00M$16.00M
Gross share repurchases———$0.00$0.00$0.00$100.0M$100.0M$0.00$100.0M$200.0M$0.00
Stock issuance proceeds$3.00M$16.00M$8.00M$7.00M$2.00M$20.00M$1.00M$4.00M$12.00M$10.00M$0.00$2.00M
Net share repurchases−$3.00M−$16.00M−$8.00M−$7.00M−$2.00M−$20.00M$99.00M$96.00M−$12.00M$90.00M$200.0M−$2.00M
Cash interest paid$252.0M$55.00M$219.0M$65.00M$211.0M$78.00M$182.0M$67.00M$195.0M$87.00M$193.0M$84.00M
Free cash flow after SBC$923.0M$240.0M−$219.0M$626.0M$778.0M$76.00M−$26.00M$445.0M$880.0M$77.00M$23.00M$757.0M

The main figures as JSON and plain text. See data and methodology.

GEHC in the terminal

Every line back twenty years, charts of any figure, segments and KPIs by quarter, valuation and alerts.